{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:18:41Z","timestamp":1791065921764,"version":"4.1.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2007,10,31]],"date-time":"2007-10-31T00:00:00Z","timestamp":1193788800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001114","type":"journal-article","created":{"date-parts":[[2007,10,30]],"date-time":"2007-10-30T22:17:25Z","timestamp":1193782645000},"page":"e1114","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Treating Cancer as an Infectious Disease\u2014Viral Antigens as Novel Targets for Treatment and Potential Prevention of Tumors of Viral Etiology"],"prefix":"10.1371","volume":"2","author":[{"given":"Xing Guo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Revskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard D.","family":"Strickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Burk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Dadachova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2007,10,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002.","volume":"118","author":"DM Parkin","year":"2006","journal-title":"Int J Cancer"},{"key":"ref2","first-page":"263","article-title":"Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis.","volume":"312","author":"E Cesarman","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref3","first-page":"795","article-title":"Cervical cancer and human papillomaviruses: inactivation of retinoblastoma and other tumor suppressor pathways.","volume":"6","author":"EE Jones","year":"2006","journal-title":"Curr Mol Med"},{"key":"ref4","first-page":"3293","article-title":"Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.","volume":"26","author":"A El-Aneed","year":"2006","journal-title":"Anticancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/JVI.80.2.845-853.2006","article-title":"Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol).","volume":"80","author":"H Arbach","year":"2006","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","article-title":"Epstein-Barr virus and oncogenesis: from latent genes to tumours.","volume":"22","author":"LS Young","year":"2003","journal-title":"Oncogene"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sj.leu.2402777","article-title":"Molecular and cellular aspects of HTLV-1 associated leukemogenesis <italic>in vivo.<\/italic>","volume":"17","author":"F Mortreux","year":"2003","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002.","volume":"55","author":"DM Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"ref9","first-page":"115S","article-title":"Perspectives on cancer therapy with radiolabeled monoclonal antibodies.","volume":"46","author":"RM Sharkey","year":"2005","journal-title":"J Nucl Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrd1413","article-title":"Antibody-targeted radiation cancer therapy.","volume":"3","author":"DE Milenic","year":"2004","journal-title":"Nature Rev Drug Discovery"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJMoa041511","article-title":"131I-tositumomab therapy as initial treatment for follicular lymphoma.","volume":"352","author":"MS Kaminski","year":"2005","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"10942","DOI":"10.1073\/pnas.1731272100","article-title":"Ionizing radiation delivered by specific antibody in therapeutic against a fungal infection.","volume":"100","author":"E Dadachova","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"ref13","first-page":"193","article-title":"Treatment of infection with radiolabeled antibodies.","volume":"50","author":"E Dadachova","year":"2006","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1371\/journal.pmed.0030427","article-title":"Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins.","volume":"3","author":"E Dadachova","year":"2006","journal-title":"PLoS Medicine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1517\/14712598.7.5.595","article-title":"Targeting viruses-harboring host cells with radiolabeled antibodies.","volume":"7","author":"A Casadevall","year":"2007","journal-title":"Expert Opinion Biol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/cbr.2007.344","article-title":"Targeting the virus with radioimmunotherapy in virus-associated cancer.","volume":"22","author":"E Dadachova","year":"2007","journal-title":"Cancer Biother Radiopharm"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective.","volume":"87","author":"FX Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"ref18","first-page":"1239","article-title":"Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence.","volume":"14","author":"NF Schlecht","year":"2005","journal-title":"Oncol Rep"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/viro.2002.1502","article-title":"Cellular steady-state levels of \u201chigh risk\u201d but not \u201clow risk\u201d human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.","volume":"299","author":"E Kehmeier","year":"2002","journal-title":"Virology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1128\/JVI.78.10.5338-5346.2004","article-title":"The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase.","volume":"78","author":"KJ Oh","year":"2004","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1128\/JCM.41.12.5598-5603.2003","article-title":"Detection of the Hepatitis B Virus X Protein (HBx) Antigen and Anti-HBx Antibodies in Cases of Human Hepatocellular Carcinoma.","volume":"41","author":"GY Hwang","year":"2003","journal-title":"J Clinical Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3748\/wjg.v13.i1.74","article-title":"Hepatitis B virus-induced oncogenesis.","volume":"13","author":"J Lupberger","year":"2007","journal-title":"World J Gastroenterol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1128\/JVI.73.12.10399-10405.1999","article-title":"The Hepatitics B virus X protein transactivates viral core gene expression in vivo.","volume":"73","author":"K Reifenberg","year":"1999","journal-title":"J. Virol."},{"key":"ref24","first-page":"4578","article-title":"Tumor necrosis treatment of ME-180 human cervical carcinoma model with 131I-labeled TNT-1 monoclonal antibody.","volume":"49","author":"FM Chen","year":"1989","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.3748\/wjg.v11.i26.4098","article-title":"Comparative study on radiosensitivity of various tumor cells and human normal liver cells.","volume":"11","author":"JS Yang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/(SICI)1097-0215(19970729)72:3<477::AID-IJC16>3.0.CO;2-9","article-title":"Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma.","volume":"72","author":"RM Sharkey","year":"1997","journal-title":"Int J Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/CMR.0b013e3282eeeae7","article-title":"Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to the metastatic melanoma tumors with wide range of melanin concentrations.","volume":"17","author":"AD Schweitzer","year":"2007","journal-title":"Melanoma Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/infdis\/165.6.1086","article-title":"Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.","volume":"165","author":"A Casadevall","year":"1992","journal-title":"J Infec Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T19:02:19Z","timestamp":1588014139000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001114"}},"subtitle":[],"editor":[{"given":"Mikhail","family":"Blagosklonny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,10,31]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2007,10,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001114","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,31]]}}}